Anika Therapeutics Announces Date for 2002 Second Quarter Financial Results Conference Call.Business Editors & Health/Medical Writers WOBURN, Mass.--(BUSINESS WIRE)--Aug. 1, 2002 Anika Therapeutics, Inc. (Nasdaq:ANIK ANIK Canadian COMSAT ) today said it plans to issue its second quarter financial results before the opening of the market on August 8, 2002. The company plans to hold a conference call that same day at 11:00 a.m. EDT EDT abbr. Eastern Daylight Time EDT Eastern Daylight Time EDT n abbr (US) (= Eastern Daylight Time) → hora de verano de Nueva York EDT to discuss quarterly financial results, business highlights and outlook. In addition, the company may answer one or more questions concerning business and financial developments and trends, and other business and financial matters affecting the company, some of the responses to which may contain information that has not been previously disclosed. To listen to the conference call, dial 706-634-1550 approximately 10 minutes before the starting time and reference Anika Therapeutics. A playback of the call will be available from 2:00 p.m. EDT Thursday, August 8 through 2:00 p.m. EDT Wednesday, August 14. To listen to the recorded call, dial 706-645-9291, access code 5068062. About Anika Therapeutics Headquartered in Woburn, Mass., Anika Therapeutics, Inc. (www.anikatherapeutics.com) develops, manufactures and commercializes therapeutic products and devices intended to promote the repair, protection and healing of bone, cartilage and soft tissue. These products are based on hyaluronic acid (HA), a naturally occurring, biocompatible biocompatible /bio·com·pat·i·ble/ (-kom-pat´i-b'l) being harmonious with life; not having toxic or injurious effects on biological function. polymer found throughout the body. In addition to ORTHOVISC(R), a treatment for osteoarthritis of the knee (not approved for sale in the U.S.), Anika markets HYVISC(R) in the U.S. for the treatment of equine osteoarthritis through Boehringer Ingelheim Vetmedica Inc. and manufactures AMVISC(R) and AMVISC(R) Plus, HA viscoelastic Adj. 1. viscoelastic - having viscous as well as elastic properties natural philosophy, physics - the science of matter and energy and their interactions; "his favorite subject was physics" products for ophthalmic surgery, for Bausch & Lomb. It also produces STAARVISC(TM)-II for distribution by STAAR STAAR Second Time Around Aussie Rescue, Inc. (Bryan, TX) STAAR Space Technology Applications Astronomy & Rocket Research (Scottish Rocket Programme) Surgical Company, Shellgel(TM) for Cytosol cytosol /cy·to·sol/ (sit´ah-sol) the liquid medium of the cytoplasm, i.e., cytoplasm minus organelles and nonmembranous insoluble components.cytosol´ic cy·to·sol n. Ophthalmics Inc. and CoEase(TM) for Allergan Inc. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion